In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Verve Therapeutics Inc’s stock clocked out at $6.41, up 4.23% from its previous closing price of $6.15. In other words, the price has increased by $4.23 from its previous closing price. On the day, 1.39 million shares were traded. VERV stock price reached its highest trading level at $7.0 during the session, while it also had its lowest trading level at $6.28.
Ratios:
To gain a deeper understanding of VERV’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.24 and its Current Ratio is at 17.24. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
On April 13, 2023, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $29.
On February 01, 2023, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $21.Cantor Fitzgerald initiated its Neutral rating on February 01, 2023, with a $21 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 02 ’24 when Nickerson Joan sold 1,514 shares for $8.24 per share. The transaction valued at 12,475 led to the insider holds 8,659 shares of the business.
Dorval Allison sold 554 shares of VERV for $6,343 on Nov 29 ’23. The Chief Financial Officer now owns 4,060 shares after completing the transaction at $11.45 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERV now has a Market Capitalization of 537945152 and an Enterprise Value of -13043422. For the stock, the TTM Price-to-Sale (P/S) ratio is 42.82 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at -1.109 whereas that against EBITDA is 0.06.
Stock Price History:
Over the past 52 weeks, VERV has reached a high of $21.42, while it has fallen to a 52-week low of $5.84. The 50-Day Moving Average of the stock is -42.14%, while the 200-Day Moving Average is calculated to be -50.08%.
Shares Statistics:
It appears that VERV traded 1.32M shares on average per day over the past three months and 1065720 shares per day over the past ten days. A total of 81.97M shares are outstanding, with a floating share count of 54.79M. Insiders hold about 30.24% of the company’s shares, while institutions hold 72.69% stake in the company. Shares short for VERV as of 1713139200 were 15694615 with a Short Ratio of 11.92, compared to 1710460800 on 14104649. Therefore, it implies a Short% of Shares Outstanding of 15694615 and a Short% of Float of 22.36.
